Shengnuo Biotechnology (688117.SH) subsidiary Shengnuo Pharmaceutical included by FDA on the 66-40 list explanation.

Zhito Finance APP News: Shengnuo Biotech (688117.SH) announced that its wholly-owned subsidiary, Chengdu Shengnuo Biopharmaceutical Co., Ltd. (hereinafter referred to as "Shengnuo Pharmaceutical"), underwent on-site inspections by the U.S. Food and Drug Administration (hereinafter referred to as "FDA") inspection team from August 20, 2026 to August 22, 2026, August 24, 2026, and August 27, 2026.